Hypercortisolism Linked to Poorly Controlled Diabetes in 24% of Patients, CATALYST Trial Finds
The CATALYST trial has identified hypercortisolism as a significant factor affecting diabetes management, offering new treatment possibilities for approximately 1.2 ...
Read more